SCHEMBL1741237

SCHEMBL1741237

NS(=O)(=O)c1cc(C(=S)S)c(N(Cc2ccco2)c2ccccc2)cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 9/20 0.52
▸ CA2 P00918 9/20 0.52
▸ CA9 Q16790 9/20 0.52
▸ CA12 O43570 8/20 0.52
▸ CA6 P23280 5/20 0.52
▸ CA7 P43166 5/20 0.52
▸ CA14 Q9ULX7 5/20 0.52
▸ CA5B Q9Y2D0 5/20 0.52
▸ CA4 P22748 4/20 0.52
▸ CA5A P35218 4/20 0.52
▸ ALDH1A1 P00352 3/20 0.52
▸ CISD1 Q9NZ45 2/20 0.52
▸ HTR1A P08908 1/20 0.52
▸ HSD11B1 P28845 1/20 0.52
▸ SLC10A1 Q14973 1/20 0.52
▸ GPR35 Q9HC97 1/20 0.52
▸ ABCG2 Q9UNQ0 1/20 0.52
▸ APP P05067 5/20 0.41
▸ TEX264 Q9Y6I9 1/20 0.41
▸ POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14541535 0.85 CA12 (0.53) CA1CA2CA9CA12CA6
SCHEMBL1743054 0.82 CA12 (0.50) CA1CA2CA9CA12CA6
SCHEMBL4697409 0.78 CA1 (0.46) CA1CA2CA9CA12CA6
SCHEMBL4697411 0.77 CA1 (0.45) CA1CA2CA9CA12CA6
SCHEMBL230681 0.77 CA12 (0.77) CA1CA2CA9CA12CA6
SCHEMBL10124068 0.74 CISD1 (0.60) CA1CA2CA9CA12CA6
SCHEMBL10108681 0.72 CISD1 (0.60) CA1CA2CA9CA12CA6
SCHEMBL4944715 0.72 CA12 (0.56) CA1CA2CA9CA12CA6
SCHEMBL230534 0.72 CA12 (0.82) CA1CA2CA9CA12CA6
SCHEMBL14399052 0.71 CISD1 (0.58) CA1CA2CA9CA12CA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2389371-A2 BUMETANIDE, FUROSEMIDE, PIRETANIDE, AZOSEMIDE, AND TORSEMIDE ANALOGS, COMPOSITIONS AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2011-11-30 — — EP disclosed
WO-2010085352-A2 BUMETANIDE, FUROSEMIDE, PIRETANIDE, AZOSEMIDE, AND TORSEMIDE ANALOGS, COMPOSITIONS AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2010-07-29 — — WO disclosed
Send feedback